85 results
425
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Business combination disclosure
9:09am
) (a) words of any gender include each other gender and neuter form; (b) words using the singular or plural number also include the plural or singular … in this Agreement to any gender include references to all genders, and references to the singular include references to the plural and vice versa. Unless
8-K
EX-2.4
c6jb7q btxaqjhkule
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
osx4y2mr
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
5us 1xn99ffcqrrosmtx
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
2yhtzsi v6r
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
evgrrjvl22gu5ia
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-10.4
3aez8zbf24z
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
ru1m3ixscz
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
4fcd bb2n5iu0j4ar
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
zwqc6z1znjsjery km
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-C
EX-2.1
krcpfy
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
bedja 8xrkzhej
10 Aug 20
Tender and Support Agreement
9:48pm
DEFA14A
lysk3a056vzq1z
4 Jun 19
Additional proxy soliciting materials
5:07pm
8-K
EX-10.1
ncyz9qsendde3d
9 Aug 18
Entry into a Material Definitive Agreement
9:05am